跳至主要内容
临床试验/CTRI/2025/11/096895
CTRI/2025/11/096895招募中2/3 期

An Open-Label Randomized Controlled Clinical Study To Evaluate The Efficacy Of Khadirashtaka Kwatha In The Management Of Chronic Urticaria (Sheetapitta)

Dr Disha Jayeshkumar Sakalshawala1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月1日最近更新:
适应症
相关药物

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Effect of Khadirashtaka Kwatha on Chronic Urticaria ( Sheetapitta)

研究概览

简要总结

The study adopts an open-label randomized controlled design, enrolling diagnosed cases of chronic urticaria. Participants will be randomly assigned to two groups—one receiving Khadirashtaka Kwatha 48 ml after meals bd with lukewarm water for 4 weeks and the other receiving Tab  Levocetirizine 5 mg at bed time once a day with water for 4 weeks. Clinical evaluation will be based on subjective parameters along with objective measures. The follow-up period will be 2 weeks.

This study seeks to scientifically validate the efficacy of Khadirashtaka Kwatha in managing Sheetapitta, correlating Ayurvedic principles with modern clinical parameters. If proven effective, this intervention could offer a holistic, safe, and sustainable approach to managing chronic urticaria, supporting the integration of Ayurvedic formulations into evidence-based clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients who have fulfilling Diagnostic criteria for Sheetapitta and the international guideline (EAACI/GA2LEN/EDF/WAO) for Chronic Urticaria.x
  • •Patients who are willing and able to participate in the study and have Chronic Urticaria, defined as an urticarial eruption for more than 6 weeks duration.
  • •Both male and female patients are between the age group of 20 – 60 years.

排除标准

  • •Patients who are less than 20 years and more than 60 years in the age group.
  • •The disease conditions and medication which will interfere the research output will be excluded.
  • •Urticaria less than 6 weeks duration.
  • •Drug induced Urticaria.
  • •Pregnant and lactating women.
  • •Patients with autoimmune diseases like Psoriasis, SLE.
  • •Patients having angioedema.

结局指标

主要结局

Effect of Khadirashtaka Kwatha on Chronic Urticaria ( Sheetapitta)

时间窗: 1st, 2nd, 3rd and 4th week. Follow up on 5th and 6th week

次要结局

  • To improve the Quality of life of the patient (QoL) of Chronic Urticaria (Sheetapitta)(1st week and 6th week)

研究者

发起方
Dr Disha Jayeshkumar Sakalshawala
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Disha Jayeshkumar Sakalshawala

G. J. Patel Institute Of Ayurvedic Studies And Research

研究点 (1)

Loading locations...

相似试验

Role of Khadirashtaka Kwatha in Skin... | 临床试验